Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Verbist

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Arzneimittel-Forschung|January 1, 1981
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermentersL Verbist
The Journal of Antimicrobial Chemotherapy|April 1, 1986
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosidesL Verbist
Antimicrobial Agents and Chemotherapy|August 1, 1979
Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organismsL Verbist
Respiration; International Review of Thoracic Diseases|January 1, 1971
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations)L Verbist
Acta Clinica Belgica|January 1, 1979
The cephalosporins: past and futureL Verbist
Drugs|January 1, 1985
Temocillin sensitivity of Enterobacteriaceae species resistant to cefotaximeL Verbist
European Journal of Clinical Microbiology|June 1, 1986
Comparative in vitro activity of the new quinolone CI-934L Verbist
Antimicrobial Agents and Chemotherapy|March 1, 1981
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilliL Verbist
The Journal of Antimicrobial Chemotherapy|February 1, 1990
The antimicrobial activity of fusidic acidL Verbist
Antimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocciL Verbist
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Arzneimittel-Forschung|January 1, 1981
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermentersL Verbist
The Journal of Antimicrobial Chemotherapy|April 1, 1986
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosidesL Verbist
Antimicrobial Agents and Chemotherapy|August 1, 1979
Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organismsL Verbist
Respiration; International Review of Thoracic Diseases|January 1, 1971
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations)L Verbist
Acta Clinica Belgica|January 1, 1979
The cephalosporins: past and futureL Verbist
Drugs|January 1, 1985
Temocillin sensitivity of Enterobacteriaceae species resistant to cefotaximeL Verbist
European Journal of Clinical Microbiology|June 1, 1986
Comparative in vitro activity of the new quinolone CI-934L Verbist
Antimicrobial Agents and Chemotherapy|March 1, 1981
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilliL Verbist
The Journal of Antimicrobial Chemotherapy|February 1, 1990
The antimicrobial activity of fusidic acidL Verbist
Antimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocciL Verbist
Pageof 16